Access cutting-edge alopecia areata treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access alopecia areata specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alopecia areata treatment provided free
The purpose of this study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the possible treatment of severe alopecia areata. Alopecia areata is a condition that causes hair loss. This study is seeking participants who have: * at least 50% scalp hair loss due to alopecia areata. * received varicella vaccination (2 doses) or have been infected by varicella zoster virus before based on blood test reports. * history of clinical response failure to alopecia a
Sponsor: Pfizer
Check if you qualify for this alopecia areata clinical trial in Portland, OR
If you're searching for alopecia areata treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alopecia areata specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.